top of page
Semaglutide + B12 (2.5mg/weekly)

Compounded Semaglutide contains the same active ingredient as Wegovy® and Ozempic®. It is prescribed to support glycemic control in adults with type 2 diabetes and may aid in weight management when used as directed by a healthcare provider.
 

Semaglutide is a GLP-1 receptor agonist that helps regulate blood sugar levels, reduce appetite, and slow gastric emptying. Vitamin B12 is included to support energy levels and normal metabolic function.
 

This formulation is supplied in a vial-and-syringe format for once-weekly subcutaneous administration, allowing for individualized dosing as prescribed.
No hidden or extra fees!Teleheath visit required.Once’s checked out. A link will be sent to complete telehealth vist.

Semaglutide + B12 (2.5mg/weekly)

SKU: 100
$400.00Price
Quantity
  • Images for illustrative purposes only.

    ✓ Supports appetite and craving control
    ✓ Convenient once-weekly injection
    ✓ Formulated with added vitamin B12 to support energy levels
    ✓ Pharmacy-compounded in the United States

  • How It Works

    Semaglutide is classified as a GLP-1 receptor agonist. It acts on physiological pathways involved in glucose regulation and appetite signaling. When prescribed by a licensed healthcare provider, it may:

    • Support appetite regulation

    • Slow gastric emptying

    • Assist with portion control

    • Support weight management when used as part of a provider-directed treatment plan

    Vitamin B12 is included to support normal energy metabolism.

    Directions for Use

    • Administer subcutaneously once weekly, as prescribed

    • Rotate injection sites between the abdomen, thigh, or upper arm

    • Store and handle the medication according to the instructions provided

    • Use only as directed by your prescribing provider

    Potential Side Effects & Warnings

    Some individuals may experience adverse effects, including but not limited to:

    • Nausea

    • Vomiting

    • Diarrhea or constipation

    • Headache

    • Fatigue

    Most side effects are transient; however, patients should discontinue use and seek medical attention if symptoms are severe, persistent, or concerning.

    Serious risks, though less common, may include gallbladder disease, pancreatitis, or hypersensitivity reactions. All risks should be discussed with a healthcare provider prior to initiation.

    Additional Information

    What Is Compounded Semaglutide?

    Compounded semaglutide is a prescription medication prepared by a licensed U.S. 503A compounding pharmacy based on an individualized prescription from a healthcare provider.

    Compounded medications are not FDA-approved and are not evaluated by the FDA for safety, efficacy, or quality.

    FDA Approval Status

    Compounded semaglutide is not FDA-approved. Compounding may be appropriate when an FDA-approved drug is not clinically suitable or commercially available for a specific patient, as determined by a prescriber.

    Relationship to FDA-Approved Semaglutide Products

    Compounded semaglutide is not the same as FDA-approved products such as Wegovy® or Ozempic®. We do not claim equivalence, bioequivalence, or superiority. Compounded formulations differ and are prepared based on provider judgment.

    Eligibility and Prescribing

    Eligibility is determined through a medical evaluation conducted by a licensed U.S. healthcare provider. The provider reviews medical history, current medications, and contraindications prior to issuing a prescription.

    Compounding and Pharmacy Standards

    Esteemed Medspa partners exclusively with licensed U.S. 503A compounding pharmacies that adhere to applicable USP standards.
    (Pharmacy details provided upon confirmation for regulatory review.)

    Esteemed Medspa does not compound, manufacture, or dispense medications.

    Available Forms

    Compounded semaglutide may be prepared in the dosage form authorized by the prescriber and supported by the compounding pharmacy, which may include:

    • Injectable formulations for subcutaneous administration

    • Oral formulations, if prescribed

    Availability varies by prescription and pharmacy capability.

    Administration

    If prescribed as an injection, compounded semaglutide is typically administered subcutaneously once weekly in the abdomen, thigh, or upper arm, in accordance with provider instructions.

    Contraindications

    Semaglutide may not be appropriate for individuals with:

    • A personal or family history of medullary thyroid carcinoma

    • Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

    • A history of pancreatitis

    • Known hypersensitivity to formulation components

    • Certain gastrointestinal disorders

    • Pregnancy or breastfeeding

    A full contraindication review is completed as part of the prescribing process.

    Monitoring and Follow-Up

    Ongoing clinical monitoring is required. Providers may adjust dosage, discontinue therapy, or recommend alternative treatment based on patient response and tolerability.

    Expected Outcomes

    Patient response varies. No specific therapeutic or weight-loss outcomes are guaranteed.

    Dispensing and Shipping

    Once prescribed, medication is prepared and dispensed by a licensed U.S. compounding pharmacy and shipped directly to the patient. Esteemed Medspa coordinates care but does not dispense medication.

    Patient Support

    Patients may contact the clinical support team through the patient portal for questions related to therapy, side effects, or refills.

    Duration of Therapy

    Length of treatment is determined by the prescribing provider based on ongoing clinical evaluation and patient response.

Related Products

bottom of page